ACM
ADAR1 Capital Management Portfolio holdings
AUM
$1.66B
1-Year Est. Return
340.85%
This Fund
S&P 500
1 Year Est. Return
+340.85%
AUM
$1.66B
AUM Growth
+$327M
(+24%)
Holding
329
Top Buys
| 1 | +$40.1M | |
| 2 | +$37.1M | |
| 3 | +$36.2M | |
| 4 |
Inspire Medical Systems
INSP
|
+$27.3M |
| 5 |
Vir Biotechnology
VIR
|
+$21.9M |
Top Sells
| 1 | +$39.4M | |
| 2 | +$17.3M | |
| 3 | +$13.2M | |
| 4 |
Fulcrum Therapeutics
FULC
|
+$10.4M |
| 5 |
Arbutus Biopharma
ABUS
|
+$9.98M |
Sector Composition
| 1 | Healthcare | 90.27% |
| 2 | Financials | 1.54% |
| 3 | Technology | 0.08% |
| 4 | Industrials | 0.08% |
| 5 | Materials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABVX
1
Abivax
ABVX
$10.6B
| $155M | 9.33% |
1,394,019
+76,690
|
|
||
2
Protagonist Therapeutics
PTGX
$6.4B
| $105M | 6.3% |
994,119
-55,049
|
|
||
3
Roivant Sciences
ROIV
$21.6B
| $91M | 5.47% |
3,285,906
-143,056
|
|
||
4
Immunovant
IMVT
$6.84B
| $66.5M | 4% |
2,679,010
+198,042
|
|
||
5
State Street SPDR S&P 500 ETF Trust
SPY
$783B
| $49.4M | 2.97% |
75,940
+21,256
|
|
||
|
TERN
6
DELISTED
Terns Pharmaceuticals
TERN
| $48.2M | 2.9% |
914,699
+373,084
|
|
||
7
Cytokinetics
CYTK
$10.4B
| $41.7M | 2.51% |
632,556
+92,390
|
|
||
8
Crinetics Pharmaceuticals
CRNX
$3.75B
| $41.4M | 2.49% |
1,139,331
+829,963
|
|
||
9
Alpha Architect 1-3 Month Box ETF
BOXX
$12.1B
| $39.2M | 2.36% |
337,125
|
|
||
10
Denali Therapeutics
DNLI
$3.34B
| $35.9M | 2.16% |
1,871,455
+1,819,339
|
|
||
11
Beam Therapeutics
BEAM
$3.39B
| $34.5M | 2.07% |
+1,446,375
|
|
||
12
Zai Lab
ZLAB
$1.99B
| $26.8M | 1.61% |
1,425,367
+178,847
|
|
||
|
SEPN
13
Septerna Inc
SEPN
$1.36B
| $26.2M | 1.57% |
1,089,818
-67,793
|
|
||
|
14
Vir Biotechnology
VIR
$1.61B
| $24.6M | 1.48% |
+2,744,714
|
|
||
|
DBVT
15
DBV Technologies
DBVT
$1.13B
| $21.2M | 1.27% |
+1,012,866
|
|
||
|
AVR
16
Anteris Technologies
AVR
$839M
| $21M | 1.26% |
3,789,132
+2,550,355
|
|
||
|
17
Inspire Medical Systems
INSP
$1.19B
| $20.9M | 1.26% |
405,197
+390,197
|
|
||
18
Scholar Rock
SRRK
$5.91B
| $20M | 1.2% |
407,273
+337,684
|
|
||
19
Rhythm Pharmaceuticals
RYTM
$6.05B
| $18.4M | 1.11% |
211,450
+160,101
|
|
||
20
Spyre Therapeutics
SYRE
$6.38B
| $17.1M | 1.03% |
338,323
+304,272
|
|
||
21
CytomX Therapeutics
CTMX
$784M
| $16M | 0.96% |
3,410,190
-772,579
|
|
||
22
Prothena Corp
PRTA
$533M
| $15.4M | 0.92% |
1,581,443
+123,679
|
|
||
23
Sanofi
SNY
$105B
| $15.3M | 0.92% |
316,939
+253,465
|
|
||
24
Vaxcyte
PCVX
$7.42B
| $15.1M | 0.91% |
259,137
-56,505
|
|
||
25
Monopar Therapeutics
MNPR
$436M
| $14.5M | 0.87% |
264,278
+30,370
|
|